Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuan-Jia Chen

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Cancer Research|February 20, 2003
Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significanceYuan-Jia Chen, Alexander Vortmeyer, Zhengping Zhuang, et al.
Cancer|March 26, 2004
X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growthYuan-Jia Chen, Alexander Vortmeyer, Zhengping Zhuang, et al.
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|April 22, 2024
Changes of soil nutrients and organic carbon fractions in <i>Caragana korshinskii</i> forests with different restoration years in mountainous areas of southern Ningxia, ChinaYu-Han Zhang, Yao Li, Yue Zhou, et al.
Zhonghua Yi Xue Za Zhi|December 1, 2004
[Frequent loss of heterozygosity at MEN-1 gene and chromosome 22q in insulinomas and its significance]Wei-Jun Jiang, Tong-Hua Liu, Jie Chen, et al.
Pancreas|December 17, 2016
A Clinicopathological Study of Malignant Insulinoma in a Contemporary SeriesRun Yu, Nicholas N Nissen, Andrew Hendifar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Overexpression of epidermal growth factor and hepatocyte growth factor receptors in a proportion of gastrinomas correlates with aggressive growth and lower curabilityPaolo L Peghini, Michiko Iwamoto, Mark Raffeld, et al.
International Journal of Clinical and Experimental Pathology|August 15, 2014
Expression of O(6)-methylguanine DNA methyltransferase (MGMT) and its clinical significance in gastroenteropancreatic neuroendocrine neoplasmQiu-Chen Yang, Yu-Hong Wang, Yuan Lin, et al.
Endocrine|February 22, 2024
SQSTM1/p62 is a prognostic molecular marker and potential therapeutic target for pancreatic neuroendocrine tumoursYu-Li Song, Jun-Hua Weng, Da-Chun Zhao, et al.
Chinese Journal of Digestive Diseases|April 29, 2006
Evaluating the role of serum elastase 1 in the diagnosis of pancreatic cancerDong Wu, Jia Ming Qian, Rui Xue Deng, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 11, 2021
Mutation and Expression of Gene YY1 in Pancreatic Neuroendocrine Tumors and Its Clinical SignificanceYu-Li Song, Jin Xu, Da-Chun Zhao, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Cancer Research|February 20, 2003
Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significanceYuan-Jia Chen, Alexander Vortmeyer, Zhengping Zhuang, et al.
Cancer|March 26, 2004
X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growthYuan-Jia Chen, Alexander Vortmeyer, Zhengping Zhuang, et al.
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|April 22, 2024
Changes of soil nutrients and organic carbon fractions in <i>Caragana korshinskii</i> forests with different restoration years in mountainous areas of southern Ningxia, ChinaYu-Han Zhang, Yao Li, Yue Zhou, et al.
Zhonghua Yi Xue Za Zhi|December 1, 2004
[Frequent loss of heterozygosity at MEN-1 gene and chromosome 22q in insulinomas and its significance]Wei-Jun Jiang, Tong-Hua Liu, Jie Chen, et al.
Pancreas|December 17, 2016
A Clinicopathological Study of Malignant Insulinoma in a Contemporary SeriesRun Yu, Nicholas N Nissen, Andrew Hendifar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Overexpression of epidermal growth factor and hepatocyte growth factor receptors in a proportion of gastrinomas correlates with aggressive growth and lower curabilityPaolo L Peghini, Michiko Iwamoto, Mark Raffeld, et al.
International Journal of Clinical and Experimental Pathology|August 15, 2014
Expression of O(6)-methylguanine DNA methyltransferase (MGMT) and its clinical significance in gastroenteropancreatic neuroendocrine neoplasmQiu-Chen Yang, Yu-Hong Wang, Yuan Lin, et al.
Endocrine|February 22, 2024
SQSTM1/p62 is a prognostic molecular marker and potential therapeutic target for pancreatic neuroendocrine tumoursYu-Li Song, Jun-Hua Weng, Da-Chun Zhao, et al.
Chinese Journal of Digestive Diseases|April 29, 2006
Evaluating the role of serum elastase 1 in the diagnosis of pancreatic cancerDong Wu, Jia Ming Qian, Rui Xue Deng, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 11, 2021
Mutation and Expression of Gene YY1 in Pancreatic Neuroendocrine Tumors and Its Clinical SignificanceYu-Li Song, Jin Xu, Da-Chun Zhao, et al.
Pageof 3